Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individually Randomised, Placebo-controlled, Parallel Arm RCT With 12-month Follow-up to Establish the Clinical and Cost Effectiveness of the Antidepressant Citalopram in the Management of Negative Symptoms of Schizophrenia

NCT01032083 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01032083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01032083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individually Randomised, Placebo-controlled, Parallel Arm RCT With 12-month Follow-up to Establish the Clinical and Cost Effectiveness of the Antidepressant Citalopram in the Management of Negative Symptoms of Schizophrenia
Lead sponsor
Imperial College London
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2011
Completion date
January 31, 2015
Enrollment
62 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia